
Company Info
Phone(301) 556-9900
Year Established
1998
Ticker
PGEN
Exchange
NASDAQ
Contacts
Helen Sabzevari, PhDPresident & CEO
Donald Lehr, JD
CLO
Rutul R. Shah
COO
Harry Thomasian Jr.
CFO
Company Description
Precigen, formerly Intrexon & Genomatix, is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.